CHAPTER 1. Industry Overview of Over-the-Counter (OTC) Drugs
1.1. Definition and Scope
1.1.1. Definition of Over-the-Counter (OTC) Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Over-the-Counter (OTC) Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Over-the-Counter (OTC) Drugs Market By Product Type
1.2.3. Over-the-Counter (OTC) Drugs Market By Distribution Channel
1.2.4. Over-the-Counter (OTC) Drugs Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Over-the-Counter (OTC) Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Over-the-Counter (OTC) Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Over-the-Counter (OTC) Drugs Major Manufacturers in 2019
CHAPTER 5. Over-the-Counter (OTC) Drugs Market By Product Type
5.1. Introduction
5.2. Over-the-Counter (OTC) Drugs Revenue By Product Type
5.2.1. Over-the-Counter (OTC) Drugs Revenue (US$ Mn) and Forecast, By Product Type, 2016-2027
5.2.2. Cough, Cold, and Flu products
5.2.2.1. Cough, Cold, and Flu products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Analgesics
5.2.3.1. Analgesics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Dermatology Products
5.2.4.1. Dermatology Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Gastrointestinal Products
5.2.5.1. Gastrointestinal Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Vitamins, Mineral, and Supplements (VMS)
5.2.6.1. Vitamins, Mineral, and Supplements (VMS) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Weight-loss/dietary products
5.2.7.1. Weight-loss/dietary products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.8. Ophthalmic Products
5.2.8.1. Ophthalmic Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.9. Sleeping Aids
5.2.9.1. Sleeping Aids Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.10. Others
5.2.10.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Over-the-Counter (OTC) Drugs Market Revenue By Distribution Channel
6.1. Introduction
6.2. Over-the-Counter (OTC) Drugs Revenue (US$ Mn) By Distribution Channel
6.2.1. Over-the-Counter (OTC) Drugs Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
6.2.2. Hospital Pharmacies
6.2.2.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Retail Pharmacies
6.2.3.1. Retail Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Online Pharmacy
6.2.4.1. Online Pharmacy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Over-the-Counter (OTC) Drugs Market By Country
7.1. North America Over-the-Counter (OTC) Drugs Overview
7.2. U.S.
7.2.1. U.S. Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.2.2. U.S. Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.3. Canada
7.3.1. Canada Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.3.2. Canada Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Over-the-Counter (OTC) Drugs Market By Country
8.1. Europe Over-the-Counter (OTC) Drugs Market Overview
8.2. U.K.
8.2.1. U.K. Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.2.2. U.K. Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.3. Germany
8.3.1. Germany Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.3.2. Germany Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.4. France
8.4.1. France Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.4.2. France Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.5. Spain
8.5.1. Spain Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.5.2. Spain Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
8.6.2. Rest of Europe Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Over-the-Counter (OTC) Drugs Market By Country
9.1. Asia Pacific Over-the-Counter (OTC) Drugs Market Overview
9.2. China
9.2.1. China Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
9.2.2. China Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.3. Japan
9.3.1. Japan Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
9.3.2. Japan Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.4. India
9.4.1. India Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
9.4.2. India Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.5. Australia
9.5.1. Australia Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
9.5.2. Australia Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
9.6.2. South Korea Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
9.7.2. Rest of Asia-Pacific Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Over-the-Counter (OTC) Drugs Market By Country
10.1. Latin America Over-the-Counter (OTC) Drugs Market Overview
10.2. Brazil
10.2.1. Brazil Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.2.2. Brazil Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.3.2. Mexico Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
10.4.2. Rest of Latin America Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
CHAPTER 11. Middle East & Africa Over-the-Counter (OTC) Drugs Market By Country
11.1. Middle East & Africa Over-the-Counter (OTC) Drugs Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.2.2. Saudi Arabia Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.3. UAE
11.3.1. UAE Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.3.2. UAE Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
11.4.2. Rest of Middle East & Africa Over-the-Counter (OTC) Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
CHAPTER 12. Player Analysis Of Over-the-Counter (OTC) Drugs
12.1. Over-the-Counter (OTC) Drugs Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Over-the-Counter (OTC) Drugs Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. COMPANY PROFILE
13.1. Johnson & Johnson Services, Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Johnson & Johnson Services, Inc. 2019 Over-the-Counter (OTC) Drugs Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Bayer AG
13.3. GlaxoSmithKline plc
13.4. Sanofi S.A.
13.5. Dr. Reddy’s Laboratories Ltd.
13.6. Cipla Limited
13.7. Others
Over-the-counter (OTC) drugs market is expected to reach a market value of around US$ 208.9 Bn by 2027.
The over-the-counter (OTC) drugs market is expected to grow at a CAGR of around 5.2% from 2020 to 2027.
Based on product type, Weight-loss/dietary products segment is the leading segment in the overall market.
Cost-benefits, positive results and broader accessibility propels the OTC drugs market globally is one of the prominent factors that drive the demand for over-the-counter (OTC) drugs market.
Johnson & Johnson Services, Inc., Bayer AG, GlaxoSmithKline plc, Sanofi S.A., Dr. Reddy’s Laboratories Ltd., Cipla Limited, and others.
North America is anticipated to grab the highest market share in the regional market
Asia Pacific is expected to be the fastest growing market in the forthcoming years
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date